Gefitinib Sandoz

Gefitinib Sandoz Indications/Uses

gefitinib

Manufacturer:

Distributor:

Marketer:

Novartis

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing

Full Prescribing Info

Indications/Uses

Gefitinib is indicated for the first line treatment of patients with locally advanced or metastatic Non-Small Cell Lung Cancer (NSCLC) who have activating mutations of the EGFR-TK (see Precautions).
Gefitinib is indicated for the treatment of patients with locally advanced or metastatic Non Small Cell Lung Cancer (NSCLC) who have previously received chemotherapy.

Asia's one-stop resource for medical news, clinical reference and education

Already a member? Sign in